Literature DB >> 21664454

The HPV16 transcriptome in cervical lesions of different grades.

Markus Schmitt1, Véronique Dalstein, Tim Waterboer, Christine Clavel, Lutz Gissmann, Michael Pawlita.   

Abstract

Infections with high-risk human papillomaviruses (HPV), mainly HPV type 16, can cause malignant transformation of the human cervical epithelium and cervical cancer (CxCa). Very little is known about the quantitative expression of HPV16 transcripts in cervical lesions of different grades. We have analysed the viral transcriptome in 80 HPV16 DNA positive cervical smears including lesions of different cytological grades, using nucleic acid sequence-based amplification (NASBA)-Luminex hybridisation assays quantifying spliced and unspliced HPV16 transcripts. Based on the quantitative analysis of single transcripts, highly significant changes in transcript levels were observed between different grades of cervical lesions. In conclusion, quantitative expression changes of HPV16 transcript markers may be involved in tumour progression. This study provides a basis for selection of candidate RNA markers for diagnostics of HPV16-related disease. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664454     DOI: 10.1016/j.mcp.2011.05.003

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  8 in total

1.  Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).

Authors:  Melanie McFarlane; Alasdair I MacDonald; Andrew Stevenson; Sheila V Graham
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

2.  Characterization of novel transcripts of human papillomavirus type 16 using cap analysis gene expression technology.

Authors:  Ayumi Taguchi; Kazunori Nagasaka; Kei Kawana; Kosuke Hashimoto; Rika Kusumoto-Matsuo; Charles Plessy; Miranda Thomas; Hiroe Nakamura; Alessandro Bonetti; Katsutoshi Oda; Iwao Kukimoto; Piero Carninci; Lawrence Banks; Yutaka Osuga; Tomoyuki Fujii
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

Review 3.  Deciphering the Multifactorial Susceptibility of Mucosal Junction Cells to HPV Infection and Related Carcinogenesis.

Authors:  Michael Herfs; Thing R Soong; Philippe Delvenne; Christopher P Crum
Journal:  Viruses       Date:  2017-04-20       Impact factor: 5.048

Review 4.  Control of human papillomavirus gene expression by alternative splicing.

Authors:  Sheila V Graham; Arwa Ali A Faizo
Journal:  Virus Res       Date:  2016-11-17       Impact factor: 3.303

5.  Performance of OncoE6 cervical test with collection methods enabling self-sampling.

Authors:  Amrei Krings; Anna M Dückelmann; Lutz Moser; Johannes Gollrad; Maarten Wiegerinck; Johannes Schweizer; Andreas M Kaufmann
Journal:  BMC Womens Health       Date:  2018-05-21       Impact factor: 2.809

6.  STOP HPV study protocol: a nationwide case-control study of the association between oropharyngeal cancer and human papillomavirus (HPV) infection in Brazil.

Authors:  Eliana Marcia Wendland; Natalia Luiza Kops; Juliana Comerlato; Jaqueline Driemeyer Correia Horvath; Marina Bessel; Daniel Sperb; Cristina Pimenta; Flávia Moreno Alves de Souza; Gerson Fernando Mendes Pereira; Frederico Soares Falcetta
Journal:  BMJ Open       Date:  2020-01-29       Impact factor: 2.692

Review 7.  Role of HPV16 E1 in cervical carcinogenesis.

Authors:  Fern Baedyananda; Thanayod Sasivimolrattana; Arkom Chaiwongkot; Shankar Varadarajan; Parvapan Bhattarakosol
Journal:  Front Cell Infect Microbiol       Date:  2022-07-28       Impact factor: 6.073

8.  Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease.

Authors:  George Chambers; David Millan; Kate Cuschieri; Heather A Cubie; Sheila V Graham
Journal:  J Med Virol       Date:  2013-10-19       Impact factor: 2.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.